Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
SymBiosis
BentonvilleSeed–Late Stage
4 people
CIBC
ChicagoPre-Seed–Late Stage$1.5M – $29.2M
Ameba Capital
ShanghaiSeed–Late Stage
3 people
Cdh Venture Management Company Limited
Hong KongSeed–Late Stage$7.1M – $300M
CDIB Capital
Hong KongSeries A–Series C$1.5M – $100M
Chang'an Capital
BeijingSeed–Series B
3 people
China Development Industrial Bank (CDIB)
TaipeiSeries A–Series B$2.8M – $51M
Company K Partners
SeoulSeed–Late Stage$2.2M – $44M
Coolidge Corner Investment
SeoulSeed–Late Stage$223K – $11M
ePlanet Capital
San JoseSeed–Late Stage
3 people
Frees Fund
BeijingPre-Seed–Series B$425K – $35M
Fubon Financial Holdings
TaipeiSeries A–Series B$5M – $27M
GVFL Ltd.
AhmedabadSeed–Late Stage$250K – $25M
Harriet Ventures
Series A–Growth$500K – $50M
Hong Kong Science and Technology Parks – incubation programs
Hong KongPre-Seed–Growth$13K – $100M
IBK Capital
SeoulSeed–Series B$2K – $21M
IMM Investment
KangnamPre-Seed–Growth$3M – $54M
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
NATO Innovation Fund
AmsterdamSeed–Series B$16.2M
3 people
Oriza Holdings
SuzhouSeed–Growth$1.7M – $200M
Quam Venture Capital
Pre-Seed–Growth$500K – $10M
SL Investment Ltd.
SeoulSeries A–Late Stage$500K – $2M
TaiAn Technologies
TaipeiSeries A–Series B$7.6M – $23M
West Virginia Jobs Investment Trust
CharlestonSeed–Late Stage$100K – $1M
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.